Novartis takes aim at drug-resistant Malaria
Novartis and Medicines for Malaria Venture (MMV) launched a patient…
FDA approved Mavyret – new drug for treating Hepatitis C
On the 3rd of August 2017, the U.S. Food and Drug Administration…
Lynparza expanding possibilities
AstraZeneca’s drug Lynparza received a new, broader approval…
FDA approved Besponsa
Yesterday Pfizer won FDA approval for a new drug for the treatment…
Parallel lines do cross
“Enabling patients’ access to medicines is no longer a job…
Positive changes in Entresto sales
When Novartis launched Entresto two years ago at a price of 4,600…